Aquilo Capital Management as of March 31, 2020
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 14 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 30.2 | $77M | 1.0M | 77.44 | |
| Uniqure Nv (QURE) | 9.3 | $24M | 502k | 47.45 | |
| Dicerna Pharmaceuticals | 8.9 | $23M | 1.2M | 18.37 | |
| Anaptysbio Inc Common (ANAB) | 7.9 | $20M | 1.4M | 14.13 | |
| Xenon Pharmaceuticals (XENE) | 6.6 | $17M | 1.5M | 11.34 | |
| Spero Therapeutics (SPRO) | 5.7 | $15M | 1.8M | 8.08 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 5.1 | $13M | 2.4M | 5.49 | |
| Ngm Biopharmaceuticals (NGM) | 5.0 | $13M | 1.0M | 12.33 | |
| Pieris Pharmaceuticals (PIRS) | 5.0 | $13M | 5.6M | 2.28 | |
| Arrowhead Pharmaceuticals (ARWR) | 4.9 | $13M | 437k | 28.77 | |
| Merus N V (MRUS) | 3.6 | $9.3M | 770k | 12.10 | |
| Regenxbio Inc equity us cm (RGNX) | 3.4 | $8.8M | 273k | 32.38 | |
| Galapagos Nv- (GLPG) | 3.4 | $8.7M | 44k | 195.91 | |
| Morphosys (MOR) | 0.9 | $2.4M | 96k | 24.57 |
